TABLE OF CONTENTS
Volume 8, Issue 1 (February 2008)
EELS (Ethical, Economic, Legal & Social) Article
I have forgotten ever having undergone heart surgery... FREE
A Palotás
Pharmacogenomics J 8: 1-3; advance online publication, February 27, 2007; doi:10.1038/sj.tpj.6500446
Reviews
The clinical role of genetic polymorphisms in drug-metabolizing enzymes FREE
D Tomalik-Scharte, A Lazar, U Fuhr and J Kirchheiner
Pharmacogenomics J 8: 4-15; advance online publication, June 5, 2007; doi:10.1038/sj.tpj.6500462
Original Articles
Rat survival to anthrax lethal toxin is likely controlled by a single gene FREE
S H Nye, A L Wittenburg, D L Evans, J A O'Connor, R J Roman and H J Jacob
Pharmacogenomics J 8: 16-22; advance online publication, April 17, 2007; doi:10.1038/sj.tpj.6500448
Megalin genetic polymorphisms and individual sensitivity to the ototoxic effect of cisplatin FREE
L Riedemann, C Lanvers, D Deuster, U Peters, J Boos, H Jürgens and A am Zehnhoff-Dinnesen
Pharmacogenomics J 8: 23-28; advance online publication, April 24, 2007; doi:10.1038/sj.tpj.6500455
Ticlopidine-induced hepatotoxicity is associated with specific human leukocyte antigen genomic subtypes in Japanese patients: a preliminary case–control study FREE
K Hirata, H Takagi, M Yamamoto, T Matsumoto, T Nishiya, K Mori, S Shimizu, H Masumoto and Y Okutani
Pharmacogenomics J 8: 29-33; advance online publication, March 6, 2007; doi:10.1038/sj.tpj.6500442
UGT1A7 polymorphisms in chronic pancreatitis: an example of genotyping pitfalls FREE
R H M te Morsche, J P H Drenth, K Truninger, H-U Schulz, A Kage, O Landt, M Verlaan, J Rosendahl, M Macek Jr, J B M J Jansen and H Witt
Pharmacogenomics J 8: 34-41; advance online publication, February 27, 2007; doi:10.1038/sj.tpj.6500443
Variability in human hepatic MRP4 expression: influence of cholestasis and genotype FREE
U Gradhand, T Lang, E Schaeffeler, H Glaeser, H Tegude, K Klein, P Fritz, G Jedlitschky, H K Kroemer, I Bachmakov, B Anwald, R Kerb, U M Zanger, M Eichelbaum, M Schwab and M F Fromm
Pharmacogenomics J 8: 42-52; advance online publication, April 3, 2007; doi:10.1038/sj.tpj.6500451
Apolipoprotein E genotype and warfarin dosing among Caucasians and African Americans FREE
S E Kimmel, J Christie, C Kealey, Z Chen, M Price, C F Thorn, C M Brensinger, C W Newcomb and A S Whitehead
Pharmacogenomics J 8: 53-60; advance online publication, February 27, 2007; doi:10.1038/sj.tpj.6500445
Whole genome expression profiling of hepatitis B virus-transfected cell line reveals the potential targets of anti-HBV drugs FREE
X R Ding, J Yang, D C Sun, S K Lou and S Q Wang
Pharmacogenomics J 8: 61-70; advance online publication, May 15, 2007; doi:10.1038/sj.tpj.6500459
The mitochondrial pharmacogenomics of haplogroup T: MTND2*LHON4917G and antiretroviral therapy-associated peripheral neuropathy FREE
J A Canter, D W Haas, A R Kallianpur, M D Ritchie, G K Robbins, R W Shafer, D B Clifford, D G Murdock and T Hulgan
Pharmacogenomics J 8: 71-77; advance online publication, August 7, 2007; doi:10.1038/sj.tpj.6500470
Polymorphisms of norepinephrine transporter and adrenergic receptor 
1D are associated with the response to 
-blockers in dilated cardiomyopathy FREE
S Nonen, H Okamoto, Y Fujio, Y Takemoto, M Yoshiyama, T Hamaguchi, Y Matsui, J Yoshikawa, A Kitabatake and J Azuma
Pharmacogenomics J 8: 78-84; advance online publication, April 3, 2007; doi:10.1038/sj.tpj.6500450
